G. M. Simpson

5.3k total citations · 2 hit papers
41 papers, 4.4k citations indexed

About

G. M. Simpson is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. M. Simpson has authored 41 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. M. Simpson's work include Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (6 papers) and Pharmaceutical studies and practices (5 papers). G. M. Simpson is often cited by papers focused on Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (6 papers) and Pharmaceutical studies and practices (5 papers). G. M. Simpson collaborates with scholars based in United States, Germany and Israel. G. M. Simpson's co-authors include J. W. S. Angus, Boris Zoubok, G. Gárdos, Michael C. Stevens, T. Scott Stroup, Ira D. Glick, José M. Cañive, M S Swartz, Matthew Byerly and Jeffrey A. Lieberman and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

G. M. Simpson

40 papers receiving 4.1k citations

Hit Papers

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS 1970 2026 1988 2007 1970 2003 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
    1970 2.9k citations G. M. Simpson et al. Acta Psychiatrica Scandinavica profile →
  2. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development
    2003 512 citations T. Scott Stroup, Joseph P. McEvoy et al. Schizophrenia Bulletin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. M. Simpson United States 16 3.6k 792 629 586 556 41 4.4k
George M. Simpson United States 39 3.1k 0.9× 889 1.1× 721 1.1× 493 0.8× 439 0.8× 154 4.4k
J. W. S. Angus United States 6 2.6k 0.7× 568 0.7× 445 0.7× 424 0.7× 367 0.7× 9 2.9k
William C. Wirshing United States 31 2.8k 0.8× 824 1.0× 426 0.7× 665 1.1× 297 0.5× 90 3.9k
Jes Gerlach Denmark 37 2.9k 0.8× 566 0.7× 502 0.8× 505 0.9× 794 1.4× 117 4.2k
Margaret G. Woerner United States 37 5.2k 1.4× 1.4k 1.8× 541 0.9× 1.4k 2.4× 905 1.6× 76 6.2k
Theodore Van Putten United States 28 2.5k 0.7× 916 1.2× 418 0.7× 727 1.2× 289 0.5× 76 3.2k
Martina Hummer Austria 31 2.9k 0.8× 681 0.9× 461 0.7× 686 1.2× 247 0.4× 69 3.7k
Guy Chouinard Canada 40 3.7k 1.0× 1.3k 1.6× 1.1k 1.7× 590 1.0× 812 1.5× 103 5.8k
Joseph Peuskens Belgium 37 3.4k 0.9× 697 0.9× 676 1.1× 638 1.1× 255 0.5× 147 4.6k
William M. Glazer United States 29 2.1k 0.6× 644 0.8× 301 0.5× 450 0.8× 577 1.0× 103 3.0k

Countries citing papers authored by G. M. Simpson

Since Specialization
Citations

This map shows the geographic impact of G. M. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. M. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. M. Simpson more than expected).

Fields of papers citing papers by G. M. Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. M. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. M. Simpson. The network helps show where G. M. Simpson may publish in the future.

Co-authorship network of co-authors of G. M. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of G. M. Simpson. A scholar is included among the top collaborators of G. M. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. M. Simpson. G. M. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stroup, T. Scott, Joseph P. McEvoy, M S Swartz, et al.. (2003). The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development. Schizophrenia Bulletin. 29(1). 15–31. 512 indexed citations breakdown →
3.
Simpson, G. M., Steven G. Potkin, Peter J. Weiden, & Richard O’Sullivan. (2000). Benefits of ziprasidone in stable outpatient schizophrenics switched from conventional antipsychotics, olanzapine, or risperidone. European Neuropsychopharmacology. 10. 289–289. 3 indexed citations
4.
León, José de, Enrique Baca‐García, & G. M. Simpson. (1998). A factor analysis of the Mini‐Mental State Examination in schizophrenic disorders. Acta Psychiatrica Scandinavica. 98(5). 366–368. 7 indexed citations
5.
Verghese, Cherian, George Abraham, Joseph K. Stanilla, et al.. (1998). Absence of Changes in Antidiuretic Hormone, Angiotensin II, and Atrial Natriuretic Peptide With Clozapine Treatment of Polydipsia-Hyponatremia. The Journal of Clinical Psychiatry. 59(8). 415–419. 10 indexed citations
6.
Stanilla, Joseph K., Christian Büchel, José de León, & G. M. Simpson. (1996). Diurnal and weekly variation of tardive dyskinesia measured by digital image processing. Psychopharmacology. 124(4). 373–376. 5 indexed citations
7.
Büchel, Christian, Wagner F. Gattaz, José de León, & G. M. Simpson. (1995). Oral tardive dyskinesia: validation of a measuring device using digital image processing. Psychopharmacology. 117(2). 162–165. 7 indexed citations
8.
Levinson, Douglas F., et al.. (1995). Fluphenazine plasma levels, dosage, efficacy, and side effects. American Journal of Psychiatry. 152(5). 765–771. 23 indexed citations
9.
León, José de, et al.. (1993). The test‐retest reliability of the Mini‐Mental State Examination in chronic schizophrenic patients. Acta Psychiatrica Scandinavica. 88(3). 188–192. 16 indexed citations
10.
Bech, Per, Ulrik Fredrik Malt, S. J. Dencker, et al.. (1993). Preface. Acta Psychiatrica Scandinavica. 87(S372). 3–3. 125 indexed citations
11.
León, José de, William H. Wilson, & G. M. Simpson. (1989). Measurement of negative symptoms in schizophrenia.. PubMed. 7(3). 211–34. 25 indexed citations
12.
Simpson, G. M., et al.. (1988). Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.. PubMed. 49(7). 258–61. 19 indexed citations
13.
Kellner, R., B. F. Sheffield, & G. M. Simpson. (1977). Comparative value of rating and self-rating scales in drug trials [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(2). 12–4. 1 indexed citations
14.
Simpson, G. M., et al.. (1976). An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia.. PubMed. 19(1). 87–98. 10 indexed citations
15.
16.
Simpson, G. M.. (1970). CONTROLLED STUDIES OF ANTIPARKINSONISM AGENTS IN THE TREATMENT OF DRUG‐INDUCED EXTRAPYRAMIDAL SYMPTOMS. Acta Psychiatrica Scandinavica. 45(S212). 44–51. 25 indexed citations
17.
18.
Simpson, G. M. & T B Cooper. (1966). THYROID INDICES IN CHRONIC SCHIZOPHRENIA: III. The Journal of Nervous and Mental Disease. 142(1). 58–62. 9 indexed citations
19.
Simpson, G. M., et al.. (1964). The clinical evaluation of a new butyrophenone (WY-3457). Psychopharmacology. 5(4). 306–312. 4 indexed citations
20.
Simpson, G. M., et al.. (1963). Perphenazine and Thyroid Function. JAMA. 186(12). 1102–1102. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George M. Simpson Breakdown of academic impact, for papers by J. W. S. Angus Breakdown of academic impact, for papers by William C. Wirshing Breakdown of academic impact, for papers by Jes Gerlach Breakdown of academic impact, for papers by Margaret G. Woerner Breakdown of academic impact, for papers by Theodore Van Putten Breakdown of academic impact, for papers by Martina Hummer Breakdown of academic impact, for papers by Guy Chouinard Breakdown of academic impact, for papers by Joseph Peuskens Breakdown of academic impact, for papers by William M. Glazer
Rankless by CCL
2026